RxDoctor Payments Data

Aeyrie Reiff, NP

Family · Phoenix, AZNPI 1730646480

Payments from drug & device makers

$1,342in general payments, 2019–2025

Across 97 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$476
  • Lilly USA, LLC$167
  • Novo Nordisk$152
  • Boehringer Ingelheim$121
  • AstraZeneca$111
  • Pfizer$59
  • plus $258 from 12 others

What the payments were for

  • Food & beverage$1,342100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,342 in reported general payments places this provider in the 75th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$8,005
Medicare patients
83
Services billed
167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,831
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,913
Albuterol Sulfate HfaAlbuterol Sulfate23$494
Lisinopril46$433
Tizanidine Hcl14$354
Fluticasone Propionate24$309
Gabapentin12$262
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$211
Ibuprofen13$208
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$179
Metformin Hcl22$154
Atorvastatin Calcium27$137
Doxycycline Hyclate12$127
Losartan Potassium12$123
Amlodipine Besylate19$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$167$11,83111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,119 family providers in Arizona.

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →